GG Group Ventures »

Verve Therapeutics shares owned by GG Group Ventures

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by GG Group Ventures from 13F filings

Historical chart of GG Group Ventures investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by GG Group Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by GG Group Ventures

Quarter filed Position value Share count Share price at filing
2024-06-30 $66k 15k 4.54

More positions owned by GG Group Ventures

Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Pacer Fds Tr Metaurus Cap 400 (QDPL)
Janus Detroit Str Tr B-bbb Clo Etf (JBBB)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)
Bank Montreal Medium NT LKD 43 (SPYU)
Direxion Shs Etf Tr Dly Smcap Bull3x (TNA)
Legg Mason Etf Invt Franklin Intl Lw (LVHI)
Direxion Shs Etf Tr Daily Msci India (INDL)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Apple (AAPL)
Direxion Shs Etf Tr Dly Midcap Etf3x (MIDU)
Intuit (INTU)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for GG Group Ventures

Top funds holding Verve Therapeutics

Alphabet
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Millennium Management
State Street Corporation
Casdin Capital
Novo A/S
Arch Venture Corp
Baker Bros. Advisors
Jpmorgan Chase & Co
Geode Capital Management
Redmile Group
Goldman Sachs Group
EcoR1 Capital

View all funds holding Verve Therapeutics